Integrated Filing — IndAS



General information about company

Scrip Code 542655
NSE Symbol VIKASLIFE
MSEI Symbol NOTLISTED
ISIN INE161L01027
Name of company VIKAS LIFECARE LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 24-06-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 19-06-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 24-06-2026   18:20:00
End date and time of board meeting 24-06-2026   22:10:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Statement on impact of audit qualification
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 11-04-2026
Indicate Company website link for updated RPT policy of the Company www.vikaslifecarelimited.com
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? Yes



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 16,584.72 49,205.46
Other income 21.76 13,350.14
Total income 16,606.48 62,555.60
2 Expenses
(a) Cost of materials consumed 593.31 1,731.23
(b) Purchases of stock-in-trade 15,658.62 46,077.80
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (49.36) 121.15
(d) Employee benefit expense 58.98 218.93
(e) Finance costs 151.96 564.43
(f) Depreciation, depletion and amortisation expense 143.77 585.11
(f) Other Expenses
1 Other Expenses 2,979.24 5,747.59
Total other expenses 2,979.24 5,747.59
Total expenses 19,536.52 55,046.24
3 Total profit before exceptional items and tax (2,930.04) 7,509.36
4 Exceptional items 0.00 0.00
5 Total profit before tax (2,930.04) 7,509.36
6 Tax expense
7 Current tax 0.00 0.00
8 Deferred tax (604.90) (1,107.88)
9 Total tax expenses (604.90) (1,107.88)
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations (2,325.14) 8,617.24
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period (2,325.14) 8,617.24
17 Other comprehensive income net of taxes (20.17) (35.60)
18 Total Comprehensive Income for the period (2,345.31) 8,581.64
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 18,598.36 18,598.36
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve 0.00
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.13 0.46
Diluted earnings (loss) per share from continuing operations 0.13 0.46
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.13 0.46
Diluted earnings (loss) per share from continuing and discontinued operations 0.13 0.46
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 2,749.45
Capital work-in-progress 0.00
Investment property 111.78
Goodwill 0.00
Other intangible assets 592.64
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 46,470.67
Trade receivables, non-current
Loans, non-current 1,564.82
Other non-current financial assets
1 Other non-current financial assets 1,049.30
Total of other non-current financial assets 1,049.30
Total non-current financial assets 49,084.79
Deferred tax assets (net) 1,464.74
Other non-current assets
1 Other non-current assets 5,097.40
2 ROU Assets 27.77
Total of other non-current assets 5,125.17
Total non-current assets 59,128.57
2 Current assets
Inventories 521.12
Current financial asset
Current investments 0.00
Trade receivables, current 13,661.71
Cash and cash equivalents 55.29
Bank balance other than cash and cash equivalents 0.00
Loans, current 0.00
Other current financial assets
Total of other current financial assets 5,893.22
Total current financial assets 19,610.22
Current tax assets (net)
Other current assets
1 Other current assets 1,284.78
2 Assets held for sale 328.20
Total of other current assets 1,612.98
Total current assets 21,744.32
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 80,872.89
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 18,598.36
Other equity 44,469.33
Total equity attributable to owners of parent 63,067.69
Non controlling interest
Total equity 63,067.69
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 2,738.37
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
1 Lease liabilities 9.50
Total of other non-current financial liabilities 9.50
Total non-current financial liabilities 2,747.87
Provisions, non-current 22.79
Deferred tax liabilities (net)
Deferred government grants, Non-current
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 2,770.66
Current liabilities
Current financial liabilities
Borrowings, current 5,444.97
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 140.69
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 5,507.09
Total Trade payable 5,647.78
Other current financial liabilities
1 Other financial liabilities 3,083.78
2 Lease liabilities current 20.96
Total of other current financial liabilities 3,104.74
Total current financial liabilities 14,197.49
Other current liabilities 528.46
1 Other current liabilities 528.46
Total of other current liabilities 528.46
Provisions, current 3.51
Current tax liabilities (Net) 305.08
Deferred government grants, Current
Total current liabilities 15,034.54
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 17,805.20
Total equity and liabilites 80,872.89
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-01-2026 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Real estate Division 0.00 0.00
2 Trading & Manufacturing Division -Polymers 1,040.37 2,726.24
3 Trading & Manufacturing Division -Agro 13,216.71 40,684.31
4 Trading & Maniufacturing Division -Infrastructure 2,327.65 5,794.92
Total Segment Revenue 16,584.73 49,205.47
Less: Inter segment revenue
Revenue from operations 16,584.73 49,205.47
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Real estate Division 0.00 0.00
2 Trading & Manufacturing Division -Polymers 99.70 137.47
3 Trading & Manufacturing Division -Agro 428.47 1,206.26
4 Trading & Maniufacturing Division -Infrastructure (146.03) (68.45)
Total Profit before tax 382.14 1,275.28
i. Finance cost 151.96 564.43
ii. Other Unallocable Expenditure net off Unallocable income 3,160.23 0.00
Profit before tax (2,930.05) 710.85
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Real estate Division 0.00 0.00
2 Trading & Manufacturing Division -Polymers 0.00 0.00
3 Trading & Manufacturing Division -Agro 0.00 0.00
4 Trading & Maniufacturing Division -Infrastructure 0.00 0.00
Total Segment Asset 0.00 0.00
Un-allocable Assets 0.00 0.00
Net Segment Asset 0.00 0.00
4 Segment Liabilities
Segment Liabilities
1 Real estate Division 0.00 0.00
2 Trading & Manufacturing Division -Polymers 0.00 0.00
3 Trading & Manufacturing Division -Agro 0.00 0.00
4 Trading & Maniufacturing Division -Infrastructure 0.00 0.00
Total Segment Liabilities 0.00 0.00
Un-allocable Liabilities 0.00 0.00
Net Segment Liabilities 0.00 0.00
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
Total Amount of items that will not be reclassified to profit and loss
2 Income tax relating to items that will not be reclassified to profit or loss 20.17 35.60
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income (20.17) (35.60)



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 7,509.36
Adjustments for reconcile profit (loss)
Adjustments for finance costs 560.94
Adjustments for decrease (increase) in inventories (42.99)
Adjustments for decrease (increase) in trade receivables, current (1,039.00)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 0.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 30,887.23
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current (76.65)
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities (2,390.99)
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 585.11
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 500.00
Adjustments for provisions, current 0.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 2,046.78
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 0.00
Adjustments for dividend income 0.00
Adjustments for interest income 0.00
Adjustments for share-based payments 685.70
Adjustments for fair value losses (gains) 2,521.22
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 0.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 34,237.35
Net cash flows from (used in) operations 41,746.71
Dividends received 0.00
Interest paid 13,178.24
Interest received 0.00
Income taxes paid (refund) 398.14
Other inflows (outflows) of cash 174.28
Net cash flows from (used in) operating activities 28,344.61
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 44,836.95
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 886.09
Purchase of property, plant and equipment 157.52
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 1,174.18
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 13,178.24
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 17.07
Net cash flows from (used in) investing activities (32,087.25)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 4,948.19
Repayments of borrowings 1,113.34
Payments of lease liabilities 0.00
Dividends paid 0.00
Interest paid 0.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (560.94)
Net cash flows from (used in) financing activities 3,273.91
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (468.73)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (468.73)
Cash and cash equivalents cash flow statement at beginning of period 524.02
Cash and cash equivalents cash flow statement at end of period 55.29





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Statement on impact of audit qualification
Auditor's opinion Qualified opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 KSMC & Associates Yes 31-05-2027


Financial details

Amount in (Lakhs)

Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income 62,555.60 62,555.60
2 Total Expenditure 55,046.24 55,046.24
3 Net Profit/(Loss) 5,617.23 5,617.23
4 Earnings Per Share 0.46 0.46
5 Total Assets 80,872.89 80,872.89
6 Total Liabilities 80,872.89 80,872.89
7 Net Worth 63,067.69 63,067.69


Audit qualification

Amount in (Lakhs)

Sr. Details of Audit Qualification Type of Audit Qualification Frequency of qualification For Audit Qualification(s) where the impact is quantified by the auditor For Audit Qualification(s) where the impact is not quantified by the auditor
Management's Views (i) Management's estimation on the impact of audit qualification (ii) If management is unable to estimate the impact, reasons for the same Auditors' Comments on (i) or (ii) above
1 Textual Information(1) Qualified opinion Whether appeared first time Textual Information(2) Textual Information(3) Textual Information(4) Textual Information(5)
2 Textual Information(6) Qualified opinion Whether appeared first time Textual Information(7) Textual Information(8) Textual Information(9) Textual Information(10)


Text Block

Textual Information(1) During the year, there were certain delays in the deposit of statutory dues by the Company. While some substantial statutory dues remained outstanding, the Company continued its business and investment activities, including investments in shares and granting of inter-corporate deposits during the year. We were not provided sufficient appropriate audit evidence with respect to business rationale of such investments and deposits and hence in view of this, we are unable to determine the impact of the said matters on the accompanying audited financial results.
Textual Information(2) The qualification arises from the audit report on the standalone financial results of Vikas Lifecare Limited ("the Company") in respect of (a) certain delays in the deposit of statutory dues, read with the Company's continued investment activities during the year, including investments in shares and the grant of inter-corporate deposits; and (b) material related party transactions for which the requisite approvals were stated to be in the process of being obtained as on that date.



The management has assessed each of the aforesaid matters as it pertains to the Company and its subsidiaries and is of the view that the same do not warrant any adjustment to the standalone financial results for the quarter and year ended March 31, 2026. The delays in the deposit of statutory dues were on account of timing reasons, and the outstanding amounts have since been / are being regularised. The investments and inter-corporate deposits were made in the ordinary course of the Company's business and investment activities, for bona fide commercial considerations and with the requisite internal approvals; the investments in shares are supported by valuation reports issued by an independent registered valuer in accordance with applicable standards. Based on its present assessment, the management considers the carrying values of such investments and the amounts recoverable in the ordinary course, and does not presently foresee any diminution or shortfall requiring recognition in the financial results.



The related party transactions were entered into in the ordinary course of business and on an arm's length basis, and the Company is in the process of obtaining the requisite shareholder approval in respect of the material related party transactions in accordance with Regulation 23 of the SEBI LODR Regulations and Section 188 of the Companies Act, 2013, read with the applicable provisions thereof.



Accordingly, in the management's view, the impact of the aforesaid qualification is presently not ascertainable / quantifiable and, based on the information available as on date, the same is not expected to have any material adverse impact on the standalone financial results of the Company for the quarter and year ended March 31, 2026.

Textual Information(3) NA
Textual Information(4) NA
Textual Information(5) In the absence of sufficient appropriate evidence regarding the business rationale, regulatory compliance and potential consequential implications, including any impact arising from regulatory proceedings, the auditor is unable to determine the impact, including whether any adjustments may be necessary to the accompanying standalone financial results for the quarter and year ended March 31, 2026
Textual Information(6) During the year ending 31st March 2026, the Company has entered into related party transactions, inter alia, in the nature of inter-corporate deposits, acquisition of investments and other transactions with its promoter group entities, subsidiaries including step down subsidiaries and/or associates and other parties which are considered material related party transactions in accordance with the provisions of Regulation 23 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR Regulations). Such transactions are also subject to compliance with the applicable provisions of Section 188 of the Companies Act, 2013 and other applicable provisions, if any.

As per the applicable provisions of the Companies Act, 2013 and Regulation 23 of the SEBI LODR Regulations, prior approval of the shareholders, wherever applicable, is required for such transactions.

As represented to us, the Company is in the process of obtaining the requisite approvals for the aforesaid transactions, which had not been obtained up to the date of approval of these financial results

Accordingly, we are unable to determine the impact, if any, of the above matter, including the consequential implications arising from non-compliance with the applicable regulatory requirements, if any, on the accompanying financial results.

Textual Information(7) The qualification arises from the audit report on the standalone financial results of Vikas Lifecare Limited ("the Company") in respect of (a) certain delays in the deposit of statutory dues, read with the Company's continued investment activities during the year, including investments in shares and the grant of inter-corporate deposits; and (b) material related party transactions for which the requisite approvals were stated to be in the process of being obtained as on that date.



The management has assessed each of the aforesaid matters as it pertains to the Company and its subsidiaries and is of the view that the same do not warrant any adjustment to the standalone financial results for the quarter and year ended March 31, 2026. The delays in the deposit of statutory dues were on account of timing reasons, and the outstanding amounts have since been / are being regularised. The investments and inter-corporate deposits were made in the ordinary course of the Company's business and investment activities, for bona fide commercial considerations and with the requisite internal approvals; the investments in shares are supported by valuation reports issued by an independent registered valuer in accordance with applicable standards. Based on its present assessment, the management considers the carrying values of such investments and the amounts recoverable in the ordinary course, and does not presently foresee any diminution or shortfall requiring recognition in the financial results.



The related party transactions were entered into in the ordinary course of business and on an arm's length basis, and the Company is in the process of obtaining the requisite shareholder approval in respect of the material related party transactions in accordance with Regulation 23 of the SEBI LODR Regulations and Section 188 of the Companies Act, 2013, read with the applicable provisions thereof.



Accordingly, in the management's view, the impact of the aforesaid qualification is presently not ascertainable / quantifiable and, based on the information available as on date, the same is not expected to have any material adverse impact on the standalone financial results of the Company for the quarter and year ended March 31, 2026.

Textual Information(8) NA
Textual Information(9) NA
Textual Information(10) In the absence of sufficient appropriate evidence regarding the business rationale, regulatory compliance and potential consequential implications, including any impact arising from regulatory proceedings, the auditor is unable to determine the impact, including whether any adjustments may be necessary to the accompanying standalone financial results for the quarter and year ended March 31, 2026


Signatories detail

Name of CEO / Managing director Sundeep Kumar Dhawan
Name of CFO Chandan Kumar
Name of audit committee chairman Richa Sharma
Name of statutory auditor Sachin Singhal
Name of other signatory, if any, with designation
Place Delhi
Date 24-06-2026


Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Vikas Lifecare Limited Sundeep Kumar Dhawan Managing Director Remuneration favorable 12.00 0.00 0.00
2 Vikas Lifecare Limited Kamal Ghildiyal Director Remuneration favorable 6.00 0.00 0.00
3 Vikas Lifecare Limited Chandan Kumar CFO cum Director Remuneration favorable 15.25 0.00 0.00
4 Vikas Lifecare Limited Sanjay Jaiswal Company Secretary Remuneration favorable 10.14 0.00 0.00
5 Vikas Lifecare Limited Vikas Ecotech Limited Related party Purchase of goods or services favorable 950.00 0.00 0.00
6 Vikas Lifecare Limited Vikas Ecotech Limited Related party Sale of goods or services favorable 2.52 0.00 0.00
7 Vikas Lifecare Limited Vikas Organics Pvt. Ltd. Related party Purchase of goods or services favorable 70.64 0.00 0.00
8 Vikas Lifecare Limited Vikas Organics Pvt. Ltd. Related party Sale of goods or services favorable 53.35 0.00 0.00
9 Vikas Lifecare Limited Vrindaa Advanced Materials Limited Related party Sale of goods or services favorable 52.72 0.00 0.00
10 Vikas Lifecare Limited Shashi Beriwal Pvt. Ltd. Subsidiary Loan favorable 54.00 0.00 0.00
11 Vikas Lifecare Limited Vikas Sports Ventures Pvt Ltd Subsidiary Loan favorable 84.28 0.00 0.00
12 Vikas Lifecare Limited IGL Genesis Technologies Ltd. Related party Loan favorable 505.00 0.00 0.00
13 Vikas Lifecare Limited Genesis Gas Solutions Private Limited Subsidiary Any other transaction Rent favorable 3.30 0.00 0.00
14 Vikas Lifecare Limited Vivek Garg Promoter Any other transaction Rent favorable 3.31 0.00 0.00
15 Vikas Lifecare Limited Seema Garg Promoter relative Any other transaction Rent favorable 5.99 0.00 0.00
16 Vikas Lifecare Limited Genesis Gas Solutions Private Limited Subsidiary Interest received favorable 0.03 0.00 0.00
17 Vikas Lifecare Limited Vikas Sports Ventures Pvt Ltd Subsidiary Interest received favorable 6.39 0.00 0.00
18 Vikas Lifecare Limited IGL Genesis Technologies Ltd. Subsidiary Interest received favorable 24.96 0.00 0.00
19 Vikas Lifecare Limited Genesis Gas Solutions Private Limited Subsidiary Interest paid favorable 5.44 0.00 0.00
20 Vikas Lifecare Limited Shashi Beriwal Pvt. Ltd. Subsidiary Interest paid favorable 4.02 0.00 0.00
21 Vikas Lifecare Limited Vikas Life Care Investment Management LLC Subsidiary Investment favorable 6.24 0.00 0.00
Total value of transaction during the reporting period 1,875.58





Format for Disclosing Outstanding Default on Loans and Debt Securities

Amount in (Lakhs)

<
Sr. No. Particulars Amount Remarks
1. Loans / revolving facilities like cash credit from banks / financial institutions
A Total amount outstanding as on date 0.00
B Of the total amount outstanding, amount of default as on date 0.00
2. Unlisted debt securities i.e. NCDs and NCRPS
A Total amount outstanding as on date 0.00
B Of the total amount outstanding, amount of default as on date 0.00
3. Total financial indebtedness of the listed entity including short-term and long-term debt 0.00